India Glycols Share Price
328.55-21.30 (-6.09%)
+67.93% past 1 Year
Financial overview
Peer Comparison
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Cash Flow
Consolidated
Standalone
₹
%
Fundamental Ratios
Consolidated
Standalone
India Glycols Share Price
328.55-21.30 (-6.09%)
+67.93% past 1 Year
Technical meters

No results found
Pivot
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
India Glycols Share Price
328.55-21.30 (-6.09%)
+67.93% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly

No results found
Bulk & block deals

No results found
Insider trading & SAST

No results found
India Glycols Share Price
328.55-21.30 (-6.09%)
+67.93% past 1 Year
Corporate Actions
Date
Type
Details
Company details
India Glycols Share Price
328.55-21.30 (-6.09%)
+67.93% past 1 Year
Corporate filings & documents

No corporate filings & documents found
India Glycols Share Price
328.55-21.30 (-6.09%)
+67.93% past 1 Year
News
Wanbury Highlights Strong Regulatory Filings And Expands United States Opportunities
Equity
WANBURY
Wanbury Receives Nine USFDA Letters Expands Metformin Business Overseas
Equity
WANBURY
ICICI Prudential Life Records Rs 98.47 Crore NSE Block Trade
Equity
ICICIPRULI
China Signals Willingness To Discuss Economic And Trade Issues With India
Broader Market
China Eases Share Buybacks Amid Stock Market Weakness
Broader Market
Amal Q2 EBITDA Margin Declines Despite Broadly Stable Operating Profit
Equity
AMAL
NCLT Rejects Rs 908 Crore Allied Silica Claim Against Tata Chemicals
Equity
TATACHEM
Amal Reports Strong Second Quarter Revenue Growth Year On Year
Equity
AMAL
Amal Reports Marginal Year On Year Growth In Second Quarter Profit
Equity
AMAL
Ujjivan Small Finance approves Rs 409.04 crore preferential equity issue
Equity
UJJIVANSFB
Aurum Reports Higher Second Quarter EBITDA And Stable Operating Margin
Equity
AURUM
Aurum PropTech Reports Strong Second Quarter Revenue Growth
Equity
AURUM
Aurum Reports Q2 Consolidated Net Profit After Year Ago Loss
Equity
AURUM
Onward Technologies Managing Director Signals Sustainable Growth Outlook After Strong First Half
Equity
ONWARDTEC
Nucleus Software launches multilingual AI tool for customized loan videos
Equity
NUCLEUS
Onward Technologies Reports Stronger Second Quarter EBIT And Margin
Equity
ONWARDTEC
Onward Technologies Reports Q2 Revenue Growth To Rs 170 Crores
Equity
ONWARDTEC
Onward Technologies Reports Strong Q2 Consolidated Net Profit Growth
Equity
ONWARDTEC
Datamatics Appoints Dr Rajesh Gharpure As Chief Operating Officer
Equity
DATAMATICS
Max Healthcare Reports Rs 51.38 Crores BSE Block Trade At Rs 845
Equity
MAXHEALTH

